Doheny Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,600
Closed -$200K 96
2021
Q3
$200K Sell
1,600
-1,150
-42% -$137K 0.14% 94
2021
Q2
$342K Sell
2,750
-140
-5% -$18.8K 0.22% 78
2021
Q1
$441K Hold
2,890
0.3% 72
2020
Q4
$372K Buy
+2,890
New +$333K 0.26% 76
2019
Q4
Sell
-7,750
Closed -$495K 97
2019
Q3
$495K Buy
+7,750
New +$683K 0.43% 63

Other funds holding GH

Doheny Asset Management's GH Position: Q4 2021 in Review

Doheny Asset Management sold out of Guardant Health (GH) in Q4 2021, closing a stake of 1,600 shares — an estimated $200K sold.

Doheny Asset Management first reported a position in GH in Q3 2019 and held it in 5 quarters. The position peaked at $495K in Q3 2019. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Doheny Asset Management reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • Doheny Asset Management sold 1,600 Guardant Health shares in Q4 2021, an estimated $200K.
  • Doheny Asset Management first reported a position in Guardant Health in Q3 2019 and held it in 5 quarters.
  • Doheny Asset Management's Guardant Health position peaked at $495K in Q3 2019.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Doheny Asset Management's 13F filing for Q4 2021, filed 15 Feb 2022.